Bordetella pertussis is an important human respiratory pathogen. Here, we describe a loop-mediated isothermal amplification (LAMP) method for the rapid detection of B. pertussis in clinical samples based on a visual test. The LAMP assay detected the BP485 target sequence within 60 min with a detection limit of 1.3 pg/µl, a 10-fold increase in sensitivity compared with conventional PCR. All 31 non-pertussis respiratory pathogens tested were negative for LAMP detection, indicating the high specificity of the primers for B. pertussis. To evaluate the application of the LAMP assay to clinical diagnosis, of 105 sputum and nasopharyngeal samples collected from the patients with suspected respiratory infections in China, a total of 12 B. pertussis isolates were identified from 33 positive samples detected by LAMP-based surveillance targeting BP485. Strikingly, a 4.5 months old baby and her mother were found to be infected with B. pertussis at the same time. All isolates belonged to different B. pertussis multilocus sequence typing groups with different alleles of the virulence-related genes including four alleles of ptxA, six of prn, four of tcfA, two of fim2, and three of fim3. The diversity of B. pertussis carrying toxin genes in clinical strains indicates a rapid and continuing evolution of B. pertussis. This combined with its high prevalence will make it difficult to control. In conclusion, we have developed a visual detection LAMP assay, which could be a useful tool for rapid B. pertussis detection, especially in situations where resources are poor and in point-of-care tests.
INTRODUCTION
Bordetella pertussis, a Gram-negative bacterium first reported in 1906 (1) , is an important human-specific respiratory pathogen that causes whooping cough (pertussis) in humans. Although the morbidity and mortality of B. pertussis have been dramatically reduced since the introduction of Pw and Pa vaccines into the routine immunization schedule of infants, pertussis is considered as the most prevalent vaccine-preventable disease (2) . It was revealed that neonates are now commonly infected by adolescents and adults, before transmitting whooping cough further to infants and other groups. This change in transmission pattern from "child to child" to "adult to child" may be the major cause for the rising incidence of pertussis, especially in developed countries with high vaccination coverage (3) (4) (5) (6) (7) . In China, pertussis is a reportable infectious disease, and although the number of reported cases has been decreasing, pertussis remains endemic. A diagnosis is made on the basis of clinical symptoms, not using diagnostic tests such as culture, PCR, and serologic analysis. Therefore, the reported low incidence may, in fact, be due to substantial underreporting caused by misdiagnosis. However, timely and accurate diagnosis is necessary for controlling the disease.
Various diagnostic tests have been established, such as culture (8) , PCR (9, 10) , real-time PCR (11, 12) , and enzyme-linked immunosorbent assay (13) . Methods based on molecular biology or immunology have become universal and are increasingly replacing culture-based methods, as they are more rapid and sensitive. However, all of the above methods are time-consuming and require specialized equipment.
Loop-mediated isothermal amplification (LAMP) is a simple and cost-effective nucleic acid amplification method, which can be applied to rapidly detect B. pertussis. A LAMP assay can be completed within 1 h at a constant temperature using simple instruments. Further advantages include its high sensitivity and specificity. LAMP has previously been used to detect B. pertussis (14) (15) (16) (17) . Previously described PCR and LAMP assays have typically used IS481, which is present in more than 200 copies in the B. pertussis genome, as the target sequence (18, 19) . However, because B. holmesii and some B. bronchiseptica strains contain the same IS481 elements, these assays lacked specificity (20, 21) . In 2008, Probert et al. compared the genomes of B. pertussis, B. bronchiseptica, and B. parapertussis, and tested the BP283 and BP485 sequences for the specific detection of B. pertussis using real-time PCR. They reported an improvement in specificity over assays targeting only IS481 (22) . Our study is the first to use BP485 as the target sequence in a LAMP assay. The purpose of the present study was to develop a rapid and simple test for B. pertussis detection, based on LAMP technology, which requires only basic www.frontiersin.org equipment and allows immediate interpretation of results by visual inspection.
MATERIALS AND METHODS

BACTERIAL ISOLATES, IDENTIFICATION, AND MLST TYPING
Thirty-four bacterial strains were used for specificity analysis, which are listed in Table 1 . Three B. pertussis vaccine strains were tested, including strain 18530, which originated from United States, strain P3s10, which has been used to produce Pw vaccines since the early 1960s, and strain CS, which has been used to produce Pa vaccines since 1995. Paired sputum and nasopharyngeal swabs were collected from 105 hospitalized patients using rayontipped swabs (Copan Diagnostics; Corona, CA, USA) between the spring of 2010 and spring of 2014. The patients (age range, 14 days to 35 years; median, 1.33 years; 52 females, 50 males) came from rural areas of China and had been treated for coughs and pneumonia for more than 7 days. Ten pairs of sputum samples and nasopharyngeal swabs from healthy people were also collected as controls. One swab or sputum sample was immediately placed in Regan-Lowe transport medium for culture and the other was stored at −70°C in an empty sterile tube for bacterial nucleic acid isolation.
Bordetella pertussis strains were cultured on Bordet-Gengou agar supplemented with 15% defibrinated sheep blood for 4-5 days at 37°C. Species identification was carried out using the Phoenix Automated Microbiology System (BD Diagnostic Systems) and matrix-assisted laser desorption ionization time-offlight (MALDI-TOF) mass spectrometry. Genomic DNA was extracted from all samples using TIANamp Bacteria DNA Kit (TIANGEN Co., Ltd., Beijing, China). The sequences of 16S ribosomal DNA (rDNA) and BP485 were validated by PCR-based sequencing and showed 100% identity with those previously reported.
Seven housekeeper genes including adk, fumC, glyA, tyrB, icd, pepA, and pgm were detected by PCR. The allele number for each gene was assigned on the basis of the information in the B. pertussis MLST database 1 . Moreover, the strains were screened for the presence of 5 virulence-related genes (prn, ptxA, tcfA, fim2, and fim3) by PCR as previously reported (23) .
PRIMER DESIGN FOR LAMP
The sequence of BP485 (Accession number: CP002695.1) was downloaded from NCBI GenBank database and further analyzed by Primer Explorer Version 4 2 . Five primer sets were designed and synthesized commercially (Sangon Biotech Co., Ltd., Shanghai, China).
LAMP ASSAY
Loop-mediated isothermal amplification assays were carried out using the Loopamp DNA Amplification kit (Eiken Chemical Co., Ltd., Tochigi, Japan). Briefly, the LAMP amplification system in a final volume of 25 µl contained 12.5 µl reaction mixture, 1 µl Bst DNA polymerase, 2 µl template for real-time turbidimeter, and During the amplification, the protectant melted and became liquid without disturbing the reaction, avoiding volatilization of amplified products after reaction, and the protectant solidified as the temperature in the tubes decreased (Patent: ZL201210371448.5 in China). Amplification was monitored using two methods, real-time changes in turbidity or visual detection of a color change. Pyrophosphate ions are released during LAMP amplification that with the addition of magnesium ions (Mg 2+ ) in the reaction buffer form a white magnesium pyrophosphate precipitate (24) , which can be monitored every 6 s at 650 nm using a real-time turbidimeter, and the data are transformed into turbidity curves. For visual detection, 1 µl of calcein/Mn 2+ fluorescent detection reagent was added to the reaction. LAMP amplification results in a green fluorescent emission as a result of magnesium ions forming a complex with calcein. The color change from orange to green when samples are positive is visible to the naked eye (25) . Each experiment was performed at least three times.
PCR ASSAY
PCRs were setup using 12.5 µl of PCR MasterMix reagents (Tiangen Biotech Co., Ltd., Beijing, China), 1 µM BP-113F3 and BP-113B3 primers, and 2 µl of DNA template in a final volume of 25 µl. PCR was performed using the following cycling conditions: initial PCR activation, 95°C for 5 min; amplification, 40 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 30 s; final extension, 72°C for 7 min. PCR products were visualized on a 1% agarose gel stained with ethidium bromide. Images were documented with a Gel Doc EQ imaging system (Bio-Rad).
RESULTS
OPTIMIZATION OF LAMP ASSAY
BP485 was targeted for detection of B. pertussis by a LAMP assay for the first time. Five different primer sets were initially tested, four of which resulted in successful amplification as shown in Figure 1 . The BP-113 primer set amplified the target sequence within the shortest time and was therefore chosen as the optimal primer set ( Table 2) .
Reaction temperatures from 60 to 67°C were compared for optimal amplification. Amplification efficiency was highest at 64°C (Figure 2 ) and was therefore used for later experiments.
SPECIFICITY OF LAMP ASSAY
To evaluate the specificity of LAMP detection for B. pertussis, genomic DNA was extracted from B. pertussis ATCC18530, B. pertussis ATCC58003, B. pertussis ATCC53894, and 31 other pathogenic respiratory bacteria and tested using real-time turbidity or visual detection of color change as readouts. Both methods of analysis positively identified the B. pertussis isolates. All other strains, including the blank control, tested negative, indicating that the LAMP assay was specific to B. pertussis (Figure 3) . 
SENSITIVITY OF THE LAMP ASSAY VERSUS PCR FOR B. PERTUSSIS
To compare the detection limit of LAMP using either real-time turbidity measurements or color change with traditional PCR, 10-fold serial dilutions of genomic DNA extracted from B. pertussis ATCC18530 (130 ng/µl to 1.3 fg/µl) were tested. The results were shown in Figure 4 . The detection limits of real-time turbidity and visual detection were both 1.3 pg/µl, which was 10-fold more sensitive than traditional PCR assay.
www.frontiersin.org FIGURE 3 | The specificity detection of LAMP assay by real-time turbidimeter (A) or addition calcein to the reaction tube (B)
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DISSEMINATION OF B. PERTUSSIS IN CLINICAL
A total of 105 clinical sputum samples and nasopharyngeal swabs were collected for LAMP-based surveillance of BP485 from patients with suspected respiratory infections in China during 2010-2014. Ten pairs of sputum samples and nasopharyngeal swabs from healthy people were collected as controls. All clinical samples were analyzed by LAMP and PCR simultaneously. As shown in Table 3 of reported genes. Multilocus sequence typing (MLST) analysis of B. pertussis showed that five of the seven housekeeping genes belonged to a single genotype, similar to reported global genotypes. However, the adk and tyrB housekeeping genes had two different genotypes belonging to type 1 and type 3, respectively.
To further characterize the virulence-related genes of the 12 isolated strains, the alleles of ptxA, prn, tcfA, fim2, and fim3 were analyzed. All isolates had virulence-related genes belonging to different genotypes with all four ptxA alleles, six prn alleles, four tcfA alleles, two fim2 alleles (fim2-1 and fim2-2), and three fim3 alleles (fim3-1, fim3-2, and fim3-4) present across the samples. Our data show that B. pertussis is widespread in respiratory infections, and the diverse genotypic features indicate on-going evolution.
DISCUSSION
Pertussis, also known as whooping cough, is an acute respiratory infectious disease caused by B. pertussis, and can cause severe disease, particularly in infants. Although vaccines are widely used in most countries, the morbidity of pertussis is rising, even in developed countries with high vaccination coverage. Remarkably, many adolescents and adults become infected despite having been vaccinated as infants as a result of waning antibody titers, which can www.frontiersin.org Nasopharyngeal swabs from healthy people 10 0 0 0 result in further transmission to children. Unfortunately, conventional wisdom holds that pertussis is a pediatric disease, leading to substantial under-diagnosis in adolescents and adults. Pertussis is highly infectious, and therefore rapid and simple methods to aid diagnosis would be advantageous in controlling disease spread. Several diagnostic techniques have been established for detecting B. pertussis, e.g., culture, serological assays, and, most commonly, PCR-based methods. These approaches are either timeconsuming or costly and frequently require skilled technicians and precision instruments. They are therefore not suitable for situations where resources are limited and fast results are required such as for point-of-care assessments. Since its introduction in 2000, a nucleic amplification method known as LAMP (26) has been widely used in various fields, including clinical diagnosis, food safety, livestock breeding, and even determination of sex (27, 28) . A number of reports indicated that LAMP had a better sensitivity and specificity for detecting pathogens than other commonly used methods. Here, we described a LAMP method for detecting BP485 of B. pertussis by color change.
Although many target genes, such as IS481, have been used to diagnose pertussis, we chose BP485, which, unlike IS481, is able to distinguish B. pertussis from B. bronchiseptica and B. parapertussis (22) . Specificity evaluation was performed here using 3 B. pertussis strains and 31 homologous species by both real-time turbidimeter and visual color change methods. All B. pertussis strains tested positive and all 31 non-pertussis respiratory tract pathogens, including B. bronchiseptica and B. parapertussis, tested negative. These results demonstrated that LAMP targeting BP485 had a high specificity for the detection of B. pertussis and that using turbidity or color change as readouts gave comparable results. The sensitivity of LAMP to detect BP485 was compared with traditional PCR using 10-fold serial dilution of genomic DNA extracted from B. pertussis. The detection limit of the LAMP assay used here was 1.3 pg/µl, 10-fold higher than conventional PCR, in agreement with previous reports. Furthermore, LAMP can be completed in one hour using a simple thermostat, whereas a PCR run takes approximately 3 h and requires a relatively complicated thermal cycler. LAMP is therefore a more rapid and simple technique making it better suited to field use.
Two readouts were used for the LAMP assay to detect amplification products, real-time turbidity and visual observation of color change. Detection by color change was as sensitive and specific as real-time turbidity measurements. As this color change is visible to the naked eye, it would further simplify the assay. It is worth noting that the use of a wax sealant over the reaction mixture was essential to minimize cross contamination by aerosol, which frequently resulted in false positives.
Application of the assay to samples taken from hospital admissions of cough and pneumonia indicated that B. pertussis was prevalent in the community with over 30% of samples testing positive. The cases included a 35-year-old female patient from rural China who was admitted for treatment in the city hospital after suffering with cough and pneumonia for 14 days. Her baby had contracted whooping cough from her as a result of close contact. This was an example of increasing numbers of "adult to child" transmissions, which may be a major factor in the rising incidence of pertussis.
In conclusion, the visual LAMP assay developed here for detecting B. pertussis allows for positive samples to be identified by the naked eye immediately after amplification is completed. The visual method is as sensitive and specific as real-time turbidity measurements and is more sensitive than PCR. It is a rapid, simple, and low-cost method to diagnose B. pertussis, making it particularly useful for point-of-care testing where time and resources are limited.
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